BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1314335)

  • 1. Heparin, fatty acids and sodium, potassium-ATPase inhibition by plasma factors during hemodialysis.
    Gault MH; Vasdev SC; Longerich L; Purchase L; Sampson C; Johnson E
    Nephron; 1992; 60(3):292-301. PubMed ID: 1314335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane incorporation of non-esterified fatty acids and effects on the sodium pump of human erythrocytes.
    Dwight JF; Mendes Ribeiro AC; Hendry BM
    Clin Sci (Lond); 1992 Jan; 82(1):99-104. PubMed ID: 1310925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids.
    Kelly RA; O'Hara DS; Mitch WE; Smith TW
    J Biol Chem; 1986 Sep; 261(25):11704-11. PubMed ID: 3017943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of unsaturated fatty acids to Na+, K(+)-ATPase leading to inhibition and inactivation.
    Swarts HG; Schuurmans Stekhoven FM; De Pont JJ
    Biochim Biophys Acta; 1990 May; 1024(1):32-40. PubMed ID: 2159804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte Na,K pump in uremia. Acute correction of a transport defect by hemodialysis.
    Izumo H; Izumo S; DeLuise M; Flier JS
    J Clin Invest; 1984 Aug; 74(2):581-8. PubMed ID: 6086716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids as endogenous Na,K-ATPase inhibitors in plasma of healthy individuals and in dialysis dependent patients.
    Vasdev SC; Longerich L; Prabhakaran VM; Triggle CR; Gault MH
    Clin Biochem; 1989 Aug; 22(4):313-9. PubMed ID: 2550162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.
    Tamura M; Kuwano H; Kinoshita T; Inagami T
    J Biol Chem; 1985 Aug; 260(17):9672-7. PubMed ID: 2991258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic and linoleic acids are active principles in Nigella sativa and stabilize an E(2)P conformation of the Na,K-ATPase. Fatty acids differentially regulate cardiac glycoside interaction with the pump.
    Mahmmoud YA; Christensen SB
    Biochim Biophys Acta; 2011 Oct; 1808(10):2413-20. PubMed ID: 21767529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-esterified fatty acids may regulate human leucocyte sodium pump activity.
    Ng LL; Hockaday TD
    Clin Sci (Lond); 1986 Dec; 71(6):737-42. PubMed ID: 3024900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis and red cell cation transport in uremia: role of membrane free fatty acids.
    Kelly RA; Canessa ML; Steinman TI; Mitch WE
    Kidney Int; 1989 Feb; 35(2):595-603. PubMed ID: 2540372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
    Tamura M; Harris TM; Higashimori K; Sweetman BJ; Blair IA; Inagami T
    Biochemistry; 1987 May; 26(10):2797-806. PubMed ID: 3038164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dialysis on circulating Na,K ATPase inhibitor in uremic patients.
    Stokes GS; Norris LA; Marwood JF; Johnston H; Caterson RJ
    Nephron; 1990; 54(2):127-33. PubMed ID: 2156180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of sodium-potassium ATPase activity in human erythrocytes in vitro.
    Lijnen P; Groeseneken D; Laermans M; Lommelen L; Piccart Y; Amery A
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):417-21. PubMed ID: 6092796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally formed dopamine inhibits Na+-K+-ATPase activity in rat renal cortical tubule cells.
    Seri I; Kone BC; Gullans SR; Aperia A; Brenner BM; Ballermann BJ
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F666-73. PubMed ID: 2845809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of alpha 1-adrenergic receptor stimulation and phorbol esters on hepatic Na+/K+-ATPase activity.
    Smart JL; Deth RC
    Pharmacology; 1988; 37(2):94-104. PubMed ID: 2905484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of individual free fatty acids in migraine.
    Anthony M
    Res Clin Stud Headache; 1978; 6():110-6. PubMed ID: 725245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ouabain receptor in animal tissues and its endogenous ligand.
    Lichtstein D; Samuelov S; Deutsch J; Xu H; Lutz RA; Chernick SS; Chernick SS
    Klin Wochenschr; 1987; 65 Suppl 8():40-8. PubMed ID: 3037184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.